Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
about
Diagnosing COPD: advances in training and practice - a systematic reviewPulmonary rehabilitation in COPD - available resources and utilization in Swedish primary and secondary careParathyroid Hormone as a Novel Biomarker for Chronic Obstructive Pulmonary Disease: Korean National Health and Nutrition Examination Survey.Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used.Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics.Persistent disabling breathlessness in chronic obstructive pulmonary disease.Validating the Concept of COPD Control: A Real-world Cohort Study from the United Kingdom.Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?Palliative care outcome measures in COPD patients: a conceptual review.How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?Prognostic variables and scores identifying the end of life in COPD: a systematic review.Comparing the 2007 and 2011 GOLD Classifications as Predictors of all-Cause Mortality and Morbidity in COPD.A comprehensive assessment using COPD assessment test scoring and modified Medical Research Council dyspnea scoring is necessary for personalized therapy for COPD patients.Dyspnoea-12: a translation and linguistic validation study in a Swedish setting.Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial.Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.The effect of environmental factors on the differential expression of miRNAs in patients with chronic obstructive pulmonary disease: a pilot clinical study.Precision medicine in COPD: where are we and where do we need to go?
P2860
Q26751313-0C8954AD-6DDF-49A0-BFA1-DC5A465BD48EQ33806754-73601B8B-D29C-40F4-91E6-F63AF820F220Q35785008-379C3C7C-51C2-4481-8C2C-4F46076B46E3Q35956001-0136FA5C-526D-47AB-BD99-D779FA57B196Q36945936-563308BF-EB1A-4E48-9E4C-AEF30455B556Q37412885-3C58813A-1FEC-4BC9-8149-7C55FE9E3F5CQ38622291-1D4F75A2-57B9-423A-B3BA-26FF36D1933FQ38711045-40E8EAA4-115A-449F-9824-D6F6E385DFF7Q38770076-DC42DB58-7486-489B-87AA-CE7865C3993FQ39030602-20E623C9-7035-4396-A26A-BCD8AB8D61F0Q39472726-5D8C94FD-12E0-4C11-B07E-E78232570DEDQ39576261-D5B4F179-707F-4B4E-A4DE-672295A3769AQ43213293-3BC4BFBF-BD10-411B-AE17-30A8BA655DA9Q47094773-139B15FF-5925-4778-9A4C-F23D92071B6BQ47096612-5C13F880-251F-49CB-8D84-CC6E2F6F1201Q47442041-2CECB60F-7E26-4CD4-8FF4-94541C0AF27BQ52347115-8AAE63C1-D184-4272-A88E-CC7722DBC45EQ54923916-95407517-4690-48B6-9B38-6184CA494C4EQ58804231-09F13A33-9CC7-45D5-92F9-84E6ECD33779
P2860
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Differential Effect of Modifie ...... Staging and Mortality in COPD.
@en
type
label
Differential Effect of Modifie ...... Staging and Mortality in COPD.
@en
prefLabel
Differential Effect of Modifie ...... Staging and Mortality in COPD.
@en
P2093
P50
P356
P1433
P1476
Differential Effect of Modifie ...... Staging and Mortality in COPD
@en
P2093
Alfredo de Diego-Damia
Alicia Marin
Antonia Llunell
COPD History Assessment in Spain (CHAIN) Cohort
Carlos Cabrera
Celia Lacarcel
Ciro Casanova
Cristina Martinez-Gonzalez
Eva Balcells
Ingrid Solanes-García
P304
P356
10.1378/CHEST.14-2449
P407
P577
2015-07-01T00:00:00Z